Abstract
Myocardial infarction constitutes an important health-related problem worldwide. Despite current treatments that salvage myocardial tissue and unload the left ventricle, chronic heart failure is common and is associated with increased morbidity and mortality. During the past decade, experimental studies, using cell-based therapies and growth factor administration integrated in biomaterial scaffolds, have demonstrated the potential to reduce the infarcted area and to improve regional and global left ventricular function. Some aspects of this rapid progress are reviewed in the present ‘special issue’ and a number of novel approaches are being introduced. This series of articles, contributed by research groups with different expertise, is a small step towards the combined efforts required to address the challenges associated with regenerating the infarcted myocardium.
Current Pharmaceutical Design
Title:Editorial: (Thematic Issue: Novel Strategies for Cardiac Repair Post-Myocardial Infarction)
Volume: 20 Issue: 12
Author(s): Simeon Agathopoulos and Theofilos M Kolettis
Affiliation:
Abstract: Myocardial infarction constitutes an important health-related problem worldwide. Despite current treatments that salvage myocardial tissue and unload the left ventricle, chronic heart failure is common and is associated with increased morbidity and mortality. During the past decade, experimental studies, using cell-based therapies and growth factor administration integrated in biomaterial scaffolds, have demonstrated the potential to reduce the infarcted area and to improve regional and global left ventricular function. Some aspects of this rapid progress are reviewed in the present ‘special issue’ and a number of novel approaches are being introduced. This series of articles, contributed by research groups with different expertise, is a small step towards the combined efforts required to address the challenges associated with regenerating the infarcted myocardium.
Export Options
About this article
Cite this article as:
Agathopoulos Simeon and Kolettis M Theofilos, Editorial: (Thematic Issue: Novel Strategies for Cardiac Repair Post-Myocardial Infarction), Current Pharmaceutical Design 2014; 20 (12) . https://dx.doi.org/10.2174/138161282012140401153832
DOI https://dx.doi.org/10.2174/138161282012140401153832 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting the Arrhythmogenic Substrate in Atrial Fibrillation: Focus on Structural Remodeling
Current Drug Targets Meet Our Associate Editor
Current Cardiology Reviews Classification of Heart Disease Using MFO Based Neural Network on MRI Images
Current Medical Imaging New and Under Explored Epigenetic Modulators in Search of New Paradigms
Medicinal Chemistry Fatty Acids - Induced Lipotoxicity and Inflammation
Current Drug Metabolism Outcomes of Patients with Chronic Heart Failure and Iron Deficiency Treated with Intravenous Iron: A Meta-analysis
Cardiovascular & Hematological Disorders-Drug Targets Autophagy: For Better or for Worse, in Good Times or in Bad Times …
Current Molecular Medicine Ion-Pair Reversed-Phase Denaturing HPLC-Based Biotechnology as a Tool for Genetic Analysis
Current Pharmaceutical Analysis Anthracycline-Induced Cardiotoxicity
Cardiovascular & Hematological Agents in Medicinal Chemistry A Novel Cancer Targeting Approach Based on Estrone Anchored Stealth Liposome for Site-Specific Breast Cancer Therapy
Current Cancer Drug Targets CD36 and Intestinal Fatty Acid Absorption
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Role of Oxidative-Nitrosative Stress and Downstream Pathways in Various Forms of Cardiomyopathy and Heart Failure
Current Vascular Pharmacology N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP): Potential target molecule in research of heart, kidney and brain
Current Pharmaceutical Design Editorial (Thematic Issue: Calcium in Heart Disease: The Ubiquitous Ion)
Medicinal Chemistry High-Density Lipoprotein at the Interface of Type 2 Diabetes Mellitus And Cardiovascular Disorders
Current Pharmaceutical Design The Critical Role of Toll-Like Receptor Signaling Pathways in the Induction and Progression of Autoimmune Diseases
Current Molecular Medicine Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management
Current Pharmaceutical Design Enterovirus D-68 Molecular Virology, Epidemiology, and Treatment: an Update and Way Forward
Infectious Disorders - Drug Targets Insights Into the Role of microRNAs in Cardiac Diseases: From Biological Signalling to Therapeutic Targets
Cardiovascular & Hematological Agents in Medicinal Chemistry Antiplatelet Therapy in Children: Why So Different from Adults’?
Current Pharmaceutical Design